Accendra Health, Inc. (ACH) Insider Trading
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Oct 2022.
Get an email when ACH's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 – Aug 14, 2025 | Coliseum Capital Partners, L.p. Large holder | Bought 3 parts | 1,537,852 | $5.27 average | $8.1M | 6.4% | Form 4 |
| Apr 8, 2025 – Apr 10, 2025 | Coliseum Capital, LLC Large holder | Bought 3 parts | 410,000 | $7.50 average | $3.07M | 1.8% | Form 4 |
| Apr 3, 2025 – Apr 7, 2025 | Coliseum Capital Management, LLC Large holder | Bought 3 parts | 528,356 | $8.12 average | $4.29M | 2.5% | Form 4 |
| Feb 28, 2025 – Mar 4, 2025 | Christopher S Shackelton Large holder | Bought 3 parts | 2,893,412 | $9.47 average | $27.4M | 17% | Form 4 |
| Nov 21, 2024 | Jonathan A Leon EVP, Chief Financial Officer | Sold10b5-1 plan | 5,282 | $11.82 | $62k | 3.9% | Form 4 |
| Nov 18, 2024 | Snehashish Sarkar Other | Sold10b5-1 plan | 2,055 | $12.26 | $25k | 3.5% | Form 4 |
- Aug 12, 2025 – Aug 14, 2025Coliseum Capital Partners, L.p.Large holder · bought 1,537,852 at avg $5.27$8.1M6.4% of stake
- Apr 8, 2025 – Apr 10, 2025Coliseum Capital, LLCLarge holder · bought 410,000 at avg $7.50$3.07M1.8% of stake
- Apr 3, 2025 – Apr 7, 2025Coliseum Capital Management, LLCLarge holder · bought 528,356 at avg $8.12$4.29M2.5% of stake
- Feb 28, 2025 – Mar 4, 2025Christopher S ShackeltonLarge holder · bought 2,893,412 at avg $9.47$27.4M17% of stake
- Nov 21, 202410b5-1 planJonathan A LeonEVP, Chief Financial Officer · sold 5,282 at $11.82$62k3.9% of stake
- Nov 18, 202410b5-1 planSnehashish SarkarOther · sold 2,055 at $12.26$25k3.5% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Spot a number that looks wrong? Check it in ACH's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ACH
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.